LABS & BIOMARKERS

NORMAL ISN'T ALWAYS OPTIMAL.

And a single laboratory result is only a snapshot.

Most laboratory testing is viewed through a simple lens:

Is the result normal or abnormal?

That's important—but longevity asks more.

A result can fall within a laboratory reference range and still be moving in an unfavorable direction.

And a single "normal" result tells you where you are at one moment in time.

It doesn't necessarily tell you where you're going.

A longevity-focused approach to biomarkers asks two additional questions:

and AM I MOVING IN THE RIGHT DIRECTION?

NORMAL VS. OPTIMAL

A reference range is not the same thing as a longevity target.

Laboratory reference ranges are useful for identifying potential abnormalities and helping diagnose disease.

But the absence of an abnormal result does not automatically mean that every marker is optimal for your long-term health.

Consider two people whose results both fall within a laboratory's reference range.

One person's biomarkers may be stable or improving.

The other's may be steadily moving in an unfavorable direction.

Both may still receive a green "NORMAL" result.

Their trajectories are not the same.

NORMAL TELLS YOU WHERE YOU FALL WITHIN A REFERENCE RANGE.

OPTIMAL ASKS WHETHER THE RESULT SUPPORTS YOUR LONG-TERM HEALTH GOALS.

There isn't one universal "optimal" number for every person or every biomarker.

Age, family history, existing disease, medications, cardiovascular and metabolic risk, body composition and other individual factors all matter.

The objective is not to redefine every normal laboratory value as abnormal.

It is to understand which biomarkers matter for you, what they mean in the context of your overall health profile, and whether there is an opportunity to improve them.

A LAB RESULT IS A SNAPSHOT

THE TREND TELLS THE STORY.

Imagine an HbA1c measured once:

HbA1c 5.6%

That is a snapshot.

Now imagine seeing:

5.2 → 5.4 → 5.6 → 5.8

The individual numbers matter.

But the trajectory tells you something the single measurement cannot.

The same principle can apply to:

ApoB

LDL-C

Triglycerides

Glucose

HbA1c

Liver enzymes

Kidney function

Hormones

and many other biomarkers.

A result doesn't necessarily need to cross into an abnormal range before the direction deserves attention.

SNAPSHOT → TREND → TRAJECTORY

DON'T JUST TRACK THE NUMBER. TRACK THE DIRECTION.

THE OPPORTUNITY IS TO RECOGNIZE CHANGE EARLIER.

Many chronic diseases develop gradually.

Metabolic dysfunction can progress for years before diabetes develops.

Atherosclerotic cardiovascular disease can develop for decades before a heart attack or stroke occurs.

Kidney function can change gradually.

Changes in other biomarkers may also emerge over time.

Traditional thresholds remain important for diagnosing disease and guiding treatment.

But a longevity strategy asks another question:

CAN WE RECOGNIZE A MEANINGFUL CHANGE BEFORE DISEASE BECOMES ESTABLISHED?

That does not mean treating every small laboratory fluctuation.

It means identifying meaningful patterns in the context of the entire health profile.

MEASURE EARLIER. RECOGNIZE THE TREND. ACT WHEN IT MATTERS.

MORE TESTING ISN'T NECESSARILY BETTER TESTING.

There are hundreds of laboratory tests that can be measured.

Longevity testing should not become an exercise in ordering everything available.

The better question is:

WHICH BIOMARKERS HELP US UNDERSTAND RISK, ESTABLISH A BASELINE OR GUIDE WHAT WE DO NEXT?

Depending on the individual, a longevity-focused laboratory profile may include measurements across several important areas.

LOOK BEYOND TOTAL CHOLESTEROL.

A standard lipid panel remains useful.

But it doesn't provide the entire cardiovascular picture.

Important measurements may include:

ApoB

Apolipoprotein B provides an estimate of the number of atherogenic lipoprotein particles circulating in the blood.

Because ApoB-containing particles play a central role in the development of atherosclerosis, ApoB can provide important information beyond LDL cholesterol alone.

Two people can have similar LDL cholesterol levels while having different numbers of ApoB-containing particles.

LDL-C TELLS US ABOUT THE CHOLESTEROL BEING CARRIED.

ApoB HELPS TELL US HOW MANY ATHEROGENIC PARTICLES ARE CARRYING IT.

That distinction can matter when assessing cardiovascular risk.

Lp(a)

Lipoprotein(a), or Lp(a), is largely genetically determined and is associated with increased cardiovascular risk.

Because Lp(a) is primarily inherited and generally remains relatively stable, measuring it at least once can identify an important risk factor that might otherwise remain hidden.

Someone can exercise regularly, maintain a healthy weight and follow a healthy lifestyle—and still have elevated Lp(a).

LDL-C

LDL cholesterol remains an important component of cardiovascular risk assessment, particularly when interpreted alongside ApoB and the rest of the individual's cardiovascular profile.

HDL-C & Triglycerides

These measurements provide additional information about lipid and metabolic health.

The objective isn't simply:

"WHAT IS MY CHOLESTEROL?"

It is:

"WHAT IS MY ATHEROSCLEROTIC CARDIOVASCULAR RISK?"

DON'T WAIT FOR DIABETES TO START PAYING ATTENTION.

Metabolic dysfunction develops along a continuum.

By the time someone meets the diagnostic criteria for diabetes, metabolic changes may have been developing for years.

Important measurements may include:

HbA1c

Hemoglobin A1c provides an estimate of average blood glucose exposure over approximately the previous several months.

One HbA1c provides useful information.

Multiple measurements reveal something more:

THE DIRECTION.

Fasting Glucose

Fasting glucose provides another view of glucose regulation.

Fasting Insulin

In selected individuals, fasting insulin may provide additional context about insulin dynamics and metabolic health.

Triglycerides

Triglycerides can also contribute to understanding metabolic health when interpreted alongside other biomarkers and body composition.

But laboratory testing should not be viewed in isolation.

Waist circumference, visceral fat, blood pressure, physical activity, cardiorespiratory fitness, sleep and nutritionhelp complete the metabolic picture.

DIABETES IS A DIAGNOSIS. METABOLIC DYSFUNCTION IS A PROCESS.

The opportunity is to identify that process earlier.

THE LIVER CAN PROVIDE IMPORTANT CLUES.

The liver plays a central role in metabolism.

Common laboratory measurements such as:

ALT

AST

Alkaline Phosphatase

Bilirubin

and other liver-related biomarkers can provide important information.

Changes in liver enzymes may have many causes and require appropriate clinical interpretation.

But when considered alongside:

Visceral fat

Metabolic health

Alcohol exposure

Medications

Nutrition

and other health information, they can contribute to a more complete picture.

The objective isn't to diagnose liver disease from a laboratory panel alone.

It is to recognize when the data suggests that something deserves further evaluation.

LONGEVITY REQUIRES PRESERVING ORGAN FUNCTION.

Kidney health is closely connected with cardiovascular and metabolic health.

Common measurements may include:

Creatinine

Estimated GFR

Electrolytes

and, when appropriate:

Urine Albumin-to-Creatinine Ratio

In selected individuals, additional markers such as cystatin C may provide useful information.

Kidney function should not be considered in isolation.

Changes can affect—and be affected by—blood pressure, diabetes, cardiovascular disease, medications, hydration and other factors.

INFLAMMATION NEEDS CONTEXT.

Inflammation is frequently discussed in longevity.

But it should not become a vague diagnosis or a reason to order indiscriminate testing.

Selected inflammatory biomarkers can sometimes provide useful information when there is a clear reason for measuring them.

For cardiovascular risk assessment, for example, **high-sensitivity C-reactive protein—or hs-CRP—**may provide additional information in selected individuals.

But an inflammatory marker is not a diagnosis by itself.

MEASURE WITH A PURPOSE. INTERPRET IN CONTEXT.

IDENTIFY WHAT MAY BE LIMITING HEALTH AND PERFORMANCE.

A complete blood count and selected nutritional biomarkers can help identify abnormalities that may affect energy, oxygen-carrying capacity, neurological function, bone health and physical performance.

Depending on the individual, measurements may include:

Complete Blood Count

Iron Studies / Ferritin

Vitamin B12

Folate

Vitamin D

and other selected nutrients when clinically appropriate.

The objective isn't to chase unusually high vitamin levels.

It is to identify meaningful deficiencies or abnormalities and address them appropriately.

07 — HORMONES

MEASURE WHEN THE RESULT CAN ANSWER A REAL QUESTION.

Hormones change with age, sex, physiology, medications and other health conditions.

Depending on symptoms, history and individual circumstances, testing may include selected measurements related to:

Thyroid Function

Testosterone

Estradiol

and other hormonal systems when appropriate.

Hormone testing should not simply become another universal longevity panel.

The important question is:

WHY ARE WE MEASURING IT?

and:

WHAT WOULD WE DO DIFFERENTLY BASED ON THE RESULT?

That same principle should apply to every biomarker.

ONE SET OF BIOMARKERS CAN INFORM MULTIPLE PARTS OF YOUR LONGEVITY PROFILE.

Laboratory biomarkers don't belong to just one category.

Many provide information relevant across the Four Horsemen evaluated within LYVYNG.

HEART

Understand the drivers of cardiovascular risk.

Measurements such as:

ApoB

Lp(a)

LDL-C

Triglycerides

HbA1c

Kidney function

and selected additional biomarkers can contribute to understanding cardiovascular risk.

Laboratory measurements cannot tell us whether coronary plaque is actually present.

But they can help identify important drivers of atherosclerotic disease.

METABOLIC

Identify metabolic change before it becomes diabetes.

HbA1c

Fasting glucose

Fasting insulin when appropriate

Triglycerides

Liver enzymes

and other measurements can help reveal patterns of metabolic dysfunction.

When combined with DEXA-derived visceral fat, waist circumference, blood pressure, physical activity and fitness, the picture becomes much more informative.

CANCER

Routine blood work is not a substitute for cancer screening.

Routine laboratory tests may sometimes reveal abnormalities that require further evaluation.

But normal routine blood work does not mean that cancer is absent.

Cancer prevention and early detection still require attention to:

Individual Risk

Family History

Genetic Risk when appropriate

Established Cancer Screening

and, when appropriate, additional early-detection strategies.

NEURODEGENERATIVE DISEASE

BRAIN HEALTH IS CONNECTED TO THE HEALTH OF THE REST OF THE BODY.

Cardiovascular and metabolic factors can influence long-term brain health.

Measurements related to:

Glucose regulation

Lipids

Kidney function

Thyroid function

Vitamin B12 and selected nutritional factors

may therefore contribute to understanding the broader context in which brain aging occurs.

There is no routine blood panel that can tell you whether you will develop a neurodegenerative disease.

The value comes from identifying modifiable factors that may influence long-term brain health and recognizing abnormalities that deserve further evaluation.

CONNECT THE BLOOD WORK TO THE REST OF THE PERSON.

ApoB means more when considered alongside cardiovascular risk and coronary imaging.

HbA1c means more when considered alongside visceral fat and physical activity.

Glucose means more when viewed over time.

Kidney function means more when considered alongside blood pressure and metabolic health.

Laboratory results become more useful when connected with:

Body Composition

Cardiovascular Imaging

Blood Pressure

VO₂ Max

Strength

Sleep

Nutrition

Exercise

Family History

Genetics

and the rest of the individual's health profile.

THE VALUE IS IN THE CONNECTIONS.

FROM MEASUREMENT TO ACTION

TESTING SHOULD HELP ANSWER: WHAT DO I DO NEXT?

Collecting more health data isn't the objective.

Using the right data to make better decisions is.

An elevated ApoB may lead to a more detailed cardiovascular assessment and a discussion about strategies to lower atherosclerotic risk.

A rising HbA1c may lead to closer evaluation of visceral fat, nutrition, exercise and metabolic health.

A nutritional deficiency may lead to correcting the deficiency and measuring again.

An abnormal liver or kidney marker may require additional medical evaluation.

Testing without an action plan produces data.

Testing with a purpose can produce useful information.

FROM SNAPSHOT TO TRAJECTORY.

LYVYNG is designed to move beyond isolated laboratory results.

A single ApoB is a snapshot.

A single HbA1c is a snapshot.

A single fasting glucose is a snapshot.

But when those measurements are followed over time—and connected with your body composition, cardiovascular imaging, fitness, lifestyle and other health information—they begin to tell a much more useful story.

WHERE WERE YOU?

WHERE ARE YOU NOW?

WHERE ARE YOU GOING?

And most importantly:

ARE YOUR ACTIONS CHANGING YOUR TRAJECTORY?

Your biomarkers can be connected to the tactics intended to change them:

EXERCISE

NUTRITION

SLEEP

MEDICATIONS, SUPPLEMENTS, HORMONES & NUTRACEUTICALS

EMOTIONAL HEALTH

Then measured again.

TRACK THE TRAJECTORY

A SINGLE RESULT IS A SNAPSHOT. YOUR HEALTH IS A TRAJECTORY.

Consider again:

HbA1c: 5.2 → 5.4 → 5.6 → 5.8

Or:

ApoB: 112 → 96 → 78 → 65

One trajectory may suggest increasing metabolic risk.

The other may show that an intervention is producing the intended change.

That is one of the fundamental principles behind LYVYNG:

DON'T JUST COLLECT RESULTS.

USE THEM TO SEE WHETHER WHAT YOU'RE DOING IS WORKING.

The same framework can connect biomarkers with:

DEXA

Visceral Fat

VO₂ Max

Grip Strength

Blood Pressure

Cardiovascular Imaging

Biological Aging

and other meaningful measurements.

Together, these create something much more useful than a collection of isolated test reports.

They create a longitudinal health profile.

NORMAL IS A RANGE.

OPTIMAL IS A GOAL.

A SINGLE RESULT IS A SNAPSHOT.

YOUR HEALTH IS A TRAJECTORY.

Know where you are.

Understand where you're going.

Take action when it matters.

Measure again.

DON'T JUST ASK, “IS IT NORMAL?”

ASK, “AM I MOVING IN THE RIGHT DIRECTION?”

[ EXPLORE LYVYNG ]

[ START MY FREE LONGEVITY ASSESSMENT ]